CNBX PHARMACEUTICALS INC. Deferred Compensation Equity
CNBX PHARMACEUTICALS INC. (CNBX) had Deferred Compensation Equity of $0 as of 2026-05-31, per its 10-Q filed 2026-06-24.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2026-06-24
- 2026-05-31: Deferred Compensation Equity $0.00.
- 2026-02-28: Deferred Compensation Equity $0.00.
- 2025-08-31: Deferred Compensation Equity $0.00.
| Period end | Deferred Compensation Equity |
|---|---|
| 2026-05-31 | $0.00 10-Q · filed 2026-06-24 |
| 2026-02-28 | $0.00 10-Q · filed 2026-04-14 |
| 2025-08-31 | $0.00 10-Q · filed 2026-06-24 |